Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tricaprilin in mild to moderate Alzheimer's disease
NCT00142805Phase 2Completed
- Sponsor
- Cerecin
- Start
- Nov 2004
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tricaprilin in Alzheimer's disease (AD), sponsored by Cerecin. Started Nov 2004; status: completed.
02
Drugs
tricaprilin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00142805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00142805.